DD298352A5 - Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung - Google Patents

Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung Download PDF

Info

Publication number
DD298352A5
DD298352A5 DD90339668A DD33966890A DD298352A5 DD 298352 A5 DD298352 A5 DD 298352A5 DD 90339668 A DD90339668 A DD 90339668A DD 33966890 A DD33966890 A DD 33966890A DD 298352 A5 DD298352 A5 DD 298352A5
Authority
DD
German Democratic Republic
Prior art keywords
tretinoin
preparation
preparation according
proteinaceous material
agent
Prior art date
Application number
DD90339668A
Other languages
German (de)
English (en)
Inventor
Elliott A Milstein
Nathan Milstein
Original Assignee
Kkk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kkk filed Critical Kkk
Publication of DD298352A5 publication Critical patent/DD298352A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD90339668A 1989-04-17 1990-04-11 Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung DD298352A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33514489A 1989-04-17 1989-04-17

Publications (1)

Publication Number Publication Date
DD298352A5 true DD298352A5 (de) 1992-02-20

Family

ID=23310461

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90339668A DD298352A5 (de) 1989-04-17 1990-04-11 Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung

Country Status (21)

Country Link
US (1) US5670547A (bg)
EP (1) EP0393904A3 (bg)
JP (1) JPH032118A (bg)
KR (1) KR900015723A (bg)
CN (1) CN1047802A (bg)
AU (1) AU633892B2 (bg)
BG (1) BG91785A (bg)
CA (1) CA2014437A1 (bg)
CS (1) CS191190A2 (bg)
DD (1) DD298352A5 (bg)
FI (1) FI901875A0 (bg)
HU (1) HUT53518A (bg)
IL (1) IL93928A0 (bg)
MY (1) MY105521A (bg)
NO (1) NO901657L (bg)
NZ (1) NZ233153A (bg)
OA (1) OA09739A (bg)
PL (1) PL284811A1 (bg)
PT (1) PT93638A (bg)
YU (1) YU70990A (bg)
ZA (1) ZA902553B (bg)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038277A (ja) * 1983-07-13 1985-02-27 パーフオーマンス・インダストリース・インコーポレーテツド モーターサイクル駆動輪の懸架装置
CA2063576C (en) * 1989-06-07 1994-01-25 Gail S. Bazzano Slow release vehicles for minimizing skin irritancy of topical compositions
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
RO115109B1 (ro) * 1993-07-01 1999-11-30 Yamanouchi Europ Bv Compozitie stabila cu retinoid
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
US6312450B1 (en) 1997-05-20 2001-11-06 Natural Vision Center, Inc. System and method for improving the appearance of skin
CN1069061C (zh) * 1997-06-03 2001-08-01 上海市第七人民医院 防治增生性疤痕胶膜及其制备方法
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US7985404B1 (en) * 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US6254594B1 (en) 1999-07-30 2001-07-03 Quadrivium, Llc Disposable light source for photothermal treatment of human tissue
DE19945522A1 (de) * 1999-09-23 2001-04-05 Hexal Ag Pharmazeutisches, wirkstoffhaltiges Gel
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
EP1261314A4 (en) * 2000-03-07 2003-06-11 Avon Prod Inc METHODS USING PHYTOL FOR IMPROVING SKIN APPEARANCE AND COMPOSITIONS THEREOF
CA2413919A1 (en) * 2000-03-21 2001-09-13 Avon Products, Inc. Methods using phytol to improve the appearance of skin and compositions for such methods
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
AU2008210557B2 (en) 2007-01-30 2013-08-01 Cypress Pharmaceutical, Inc. Hyaluronate compositions
CA2686558A1 (fr) * 2007-05-11 2008-12-11 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
US20100029765A1 (en) * 2008-07-30 2010-02-04 Ranbaxy Labortories Limited Topical aqueous composition comprising tretinoin
US20100113352A1 (en) * 2008-11-06 2010-05-06 Elliott Millstein Retinol formulations and methods for their use
US10653656B2 (en) * 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions
CN110893155A (zh) * 2018-09-12 2020-03-20 广州赛度检测服务有限公司 一种皮肤保湿护肤品及其制备工艺
CA3133807A1 (en) * 2019-03-18 2020-09-24 Bausch Health Ireland Limited Topical compositions and methods for treating acne vulgaris

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
IN142640B (bg) * 1975-01-17 1977-08-06 Johnson & Johnson
US4073291A (en) * 1976-07-28 1978-02-14 Johnson & Johnson Topical device for administering tretinoin
US4186207A (en) * 1976-09-01 1980-01-29 Henkel Kommanditgesellschaft Auf Aktien Stable aqueous or aqueous-alcoholic solutions of fat-soluble perfume oils or drugs containing N-(hydroxyalkyl)amide-ethoxylates
BR7904612A (pt) * 1978-07-24 1980-04-08 Unilever Nv Composicao cosmeticamente aceitavel para aplicacao topica,processo para preparar uma composicao,aplicador e processopara prover vantagem a pele
US4588744A (en) * 1978-09-19 1986-05-13 Mchugh John E Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide
US4256763A (en) * 1978-09-19 1981-03-17 Mchugh John E Treatment of herpes simplex infections and acne
US4214000A (en) * 1978-10-30 1980-07-22 Johnson & Johnson Zinc salt of all-trans-retinoic acid for the treatment of acne
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4323557A (en) * 1979-07-31 1982-04-06 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesive containing iodine
US4310509A (en) * 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4443442A (en) * 1979-12-21 1984-04-17 Skillern Scott D Method and composition for treatment of acne vulgaris
US4591501A (en) * 1981-04-13 1986-05-27 Seton Company Cosmetic and pharmaceutical sheet material containing polypeptides
IL65588A (en) * 1981-07-10 1985-04-30 Orion Yhtymae Oy Pharmaceutical compositions for the treatment of skin
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4454159A (en) * 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
US4428933A (en) * 1982-08-02 1984-01-31 King John R Composition for treating acne, method of manufacturing said composition, and method of treating skin
US4690775A (en) * 1983-09-30 1987-09-01 Research Corporation Emulsion-based gel and process for preparing same
LU85083A1 (fr) * 1983-11-09 1985-07-17 Oreal Composition cosmetique ou pharmaceutique sous forme d'un baton ou stick constitue de deux phases grasses concentriques,son procede de preparation et etui en permettant sa conservation et sa distribution
FR2555571B1 (fr) * 1983-11-28 1986-11-28 Interna Rech Dermatolo Centre Derives du naphtalene, leur procede de preparation et leur application dans le domaine therapeutique
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4649040A (en) * 1984-05-04 1987-03-10 The United States Of America As Represented By The Department Of Health And Human Services Therapy for retinoid pathogenesis
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US4826828A (en) * 1985-04-22 1989-05-02 Avon Products, Inc. Composition and method for reducing wrinkles
US4677120A (en) * 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4786436A (en) * 1986-01-31 1988-11-22 Bausch & Lomb Incorporated Wetting solutions for contact lenses

Also Published As

Publication number Publication date
MY105521A (en) 1994-10-31
PT93638A (pt) 1990-11-20
IL93928A0 (en) 1990-12-23
ZA902553B (en) 1991-01-30
HU902444D0 (en) 1990-08-28
CS191190A2 (en) 1991-09-15
PL284811A1 (en) 1991-01-14
HUT53518A (en) 1990-11-28
BG91785A (bg) 1993-12-24
CN1047802A (zh) 1990-12-19
JPH032118A (ja) 1991-01-08
KR900015723A (ko) 1990-11-10
AU5296890A (en) 1990-10-18
AU633892B2 (en) 1993-02-11
FI901875A0 (fi) 1990-04-12
CA2014437A1 (en) 1990-10-17
YU70990A (en) 1992-05-28
NO901657D0 (no) 1990-04-11
OA09739A (en) 1993-11-30
EP0393904A2 (en) 1990-10-24
EP0393904A3 (en) 1991-05-02
NZ233153A (en) 1992-04-28
US5670547A (en) 1997-09-23
NO901657L (no) 1990-10-18

Similar Documents

Publication Publication Date Title
DD298352A5 (de) Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung
DE68914365T2 (de) Topische metronidazol-formulationen und deren verwendung als arzneimittel.
DE69029804T2 (de) VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
DE69427639T3 (de) Verwendung von nicht-ionischen oberflächenaktiven substanzen in retinoid enthaltenden stabilen topischen zusammensetzungen
AT390372B (de) Verwendung von solarfiltern zur stabilisierung und verbesserung der hautvertraeglichkeit von benzoylperoxyd enthaltenden zubereitungen zur lokalen aknebehandlung
DE69926843T2 (de) Aktives vitamin-d3 enthaltende lotionen in form von emulsionen
DE69930004T2 (de) Wasserfreie ketoconazole enthaltende zubereitungen zur topischen applikation auf die haut
DE69736998T2 (de) Nitroimidazol enthaltende gelzusammensetzung
DE69324011T2 (de) Distickstoffmonoxide enthaldendes dermatologisches präparat
DE2448871A1 (de) Stabilisierte trans-retinsaeurecreme
EP0378852B1 (de) Topisch anwendbare pharmazeutische Zubereitung
DE2721831A1 (de) Entzuendungshemmende, topisch anzuwendende arzneipraeparate
EP0367103B1 (de) Topische Salbe
DE2924005C2 (de) Isosorbiddinitrat enthaltendes Mittel
DE68907335T2 (de) Im wesentlichen aus Triglyceriden gesättigter Fettsäuren bestehende, mit einem Wirkstoff beladene Mikrogranulate und ihre äusserliche therapeutische Anwendung.
DE2601489C2 (bg)
DE69022314T2 (de) Stabile emulgierte Tretinoin-Cremeformulierungen.
EP1569724A1 (de) Formulierungen enthaltend melatonin, ginkgo biloba und biotin
DE69332378T2 (de) Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung
DE69804130T2 (de) Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen
DE3049722C2 (de) Zur Behandlung von Akne und Seborrhoe geeignete, wäßrige Benzoylperoxidzusammensetzung
EP1967180A1 (de) Topische Zusammensetzung enthaltend einen Retinoid-Rezeptor-Agonist
DE19940227A1 (de) Phospholipidgel
DE2748399C2 (de) Antimikrobielles Mittel zur örtlichen Anwendung
DE69300854T2 (de) Mittel zur topischen Verabreichung von Spironolakton.

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100412